Prevest Denpro informs about outcome of board meeting

08 Nov 2021 Evaluate

Pursuant to the Regulation 30 and 33 read with Schedule Ill of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Prevest Denpro has informed that the Board of Directors, at its meeting held on Monday, 08th  November, 2021, approved Un-Audited Financial Results for the Half Year ended on 30th September, 2021 along with Statement of Assets and Liabilities and Cash Flow Statement (Copy enclosed) and  Limited Review Report for the Half Year ended on 30th September, 2021 (Copy enclosed).

The above information is a part of company’s filings submitted to BSE.

Prevest Denpro Share Price

572.25 -7.25 (-1.25%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Poly Medicure 2597.75
Hemant Surgical Inds 126.85
Nureca Ltd. 281.05
Prevest Denpro 572.25
Centenial Surgical 137.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.